tirzepatide throwing up and diarrhea The standard 2.5 mg starting dose of may be too high for some people. Some clinicians use lower customized doses in sensitive patients to reduce nausea, fatigue excessive appetite suppression How to Minimize Nausea on

[Accessed on February 12, 2026] Mounjaro KwikPen 2.5 mg solution for injection

Studies have consistently found that people with diabetes have a 5090% increased risk of disability, and a variety of factors are associated with this risk

Your body writes the final answer

Contact your healthcare provider if hair loss persists beyond 6 months, worsens despite stable weight, or occurs alongside other symptoms like fatigue or nail brittlenesssigns that may indicate nutritional deficiency

Tirzepatide, a dual receptor agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) helps in weight loss, but its effects on cardiovascular outcomes are unclear